Pentec Health Launches the Targeted Drug Delivery Network

Company powers first online forum exclusively for targeted drug delivery.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Launching the TDDN provides endless opportunities for the advancement of targeted drug delivery through the sharing of information, personal experiences and clinical research.

Philadelphia, Pennsylvania (PRWEB) December 17, 2013

Pentec Health, Inc. introduced the Targeted Drug Delivery Network today at the 17th annual North American Neuromodulation Society (NANS) Conference in Las Vegas, NV. This represents the first ever, secured, online forum exclusively focused on healthcare professionals that utilize implanted drug delivery systems to treat severe pain and spasticity. The Targeted Drug Delivery Network (TDDN) is a totally unique, private, social network where physicians, scientists and biomedical engineers can access and share the most current and relevant information and data pertaining to their specialized area of medicine.

According to Michael Abens, General Manager and Executive Vice President at Pentec Health, Inc., TDDN is a specialized communication platform for discussion and discovery. “We believe in utilizing the latest technology to foster professional connectivity,” he stated. “Launching the TDDN provides endless opportunities for the advancement of targeted drug delivery through the sharing of information, personal experiences and clinical research. Physicians now have a centralized, virtual location to easily access each other in a more convenient way to discuss important topics.”

“In the age of social media and generalized medical chat boards, it is wonderful to have a web destination that is so specific to targeted drug delivery. I am looking forward to the possibilities this unique forum will create,” stated Dr. Rodney V. Chou, M.D., Medical Director at Pentec Health.

The Targeted Drug Delivery Network will also provide a calendar that contains current information on relevant meetings and conferences.

Dr. Stanley P. Fisher, M.D., Co-Director of Movement Disorders and Neurorehabilitation Center at Houston Methodist Neurological Institute and Associate Professor of Clinical Neurology at Weill Cornell Medical College of Cornell University, is thrilled at the idea of “instant communication.” He adds, “The TDDN can provide a direct route to the most current data, publications and information. Just as important as the access to the information, is the access to the key people. Too often I have to go through several channels to access physicians in different parts of the country if I have patients who are travelling or relocating. Now I have a direct route to the information I need to find out who is doing the latest procedures and where. The future of medicine is in ideas. In order to power our field forward, we needed a better form of communication to share those ideas. Thanks to Pentec Health, we now have it.”

About Pentec Health, Inc.
Pentec Health, Inc. is a privately-held national provider of proprietary nutritional infusion therapies for patients suffering from chronic kidney disease and offers specialized pharmacy and nursing services for patients with implanted drug delivery pumps treating severe pain and spasticity. The company is headquartered in suburban Philadelphia and is proud to be celebrating its 30th year in business. The Joint Commission has consistently awarded Pentec with its Gold Seal of Approval for their commitment to providing the highest level of patient safety and patient care for renal nutrition and specialty infusion home care services. For more information, visit http://www.pentechealth.com.


Contact

  • Monique Costa
    PentecHealth
    +1 (856) 906-7833
    Email